家族性腺瘤性息肉病胃底腺息肉的新型内镜下息肉切除术监测技术可改善异型增生和胃癌的早期检测
本文为回顾性纵向队列研究,纳入2001至2019年间在某三级中心接受监测的35例家族性腺瘤性息肉病患者,评估新型内镜下息肉切除术(EPS,大容量冷圈套息肉切除术)随机切除胃底腺息肉对异型增生和胃癌检出率的作用。结果显示异型增生和胃癌发生率高于既往报道,EPS可在胃底腺息肉灶内识别胃癌。
要点
- 35例家族性腺瘤性息肉病患者中,初始食管胃十二指肠镜检出胃底腺息肉异型增生7例(20%)。
- 另有13例(46.4%)进展为低级别异型增生,3例(15%)后续进展为胃癌。
- 息肉>10 mm(P<0.001)和息肉铺路石样分布(P<0.001)为癌症的内镜危险因素。
核心结论
- 家族性腺瘤性息肉病患者中异型增生和胃癌的发生率高于既往报道。
- 本研究采用新型EPS技术,能够在胃底腺息肉灶内识别胃癌。
- 上消化道内镜指南应纳入更严格的胃底腺息肉取样方法(如EPS),以优化异型增生和胃癌的早期检测。
研究设计与样本
- 回顾性纵向队列研究。
- 纳入2001至2019年间转诊至某三级中心进行十二指肠腺瘤监测并接受胃底腺息肉EPS的家族性腺瘤性息肉病患者35例。
- 共完成113次监测性内镜检查并使用EPS。
- 患者初次内镜检查时平均年龄43.4岁(±12.8)。
主要发现
- 初始食管胃十二指肠镜检出胃底腺息肉异型增生7例(20%)。
- 另有13例(46.4%)进展为低级别异型增生。
- 3例(15%)后续进展为胃癌,经EPS在胃底腺息肉灶内发现印戒细胞癌;其中1例表现为转移性胃癌。
- 从无异型增生胃底腺息肉进展为低级别异型增生历时63个月(±46.3),进一步进展为胃癌历时34个月(±8.5)。
- 癌症的内镜危险因素为息肉>10 mm(P<0.001)和息肉铺路石样分布(P<0.001);发生异型增生的5年累积发生率为35.7%。
关键数值与推荐
- 癌症的内镜危险因素:息肉>10 mm(P<0.001)。
- 癌症的内镜危险因素:息肉铺路石样分布(P<0.001)。
- 发生异型增生的5年累积发生率为35.7%。
临床怎么用
- 作者认为上消化道内镜指南应纳入更严格的胃底腺息肉取样方法(如EPS),以优化异型增生和胃癌的早期检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Fundic gland polyps (FGPs) are commonly found in patients with familial adenomatous polyposis (FAP) and are considered benign. Biopsies are not routinely performed, and conventional forceps may be time-consuming and/or yield nonrepresentative histology. The purpose of this study was to evaluate the role of a novel endoscopic polypectomy surveillance (EPS), a large volume cold-snare polypectomy technique of random FGPs, in the incidence of dysplasia and gastric cancer (GC) in FAP. METHODS: This is a retrospective longitudinal cohort of patients with FAP referred to a tertiary care center for duodenal adenoma surveillance and who underwent EPS of FGPs between 2001 and 2019. Demographic, endoscopic, and clinicopathologic information was reviewed. RESULTS: Thirty-five patients with FAP were identified at initial endoscopy by the mean age of 43.4 years (±12.8). One hundred thirteen surveillance endoscopies were performed in total using EPS. Dysplasia of FGPs was present on initial esophagogastroduodenoscopy in 7 patients (20%), and 13 additional patients (46.4%) progressed to low-grade dysplasia. Three patients (15%) who subsequently had progression to GC were found to have signet ring cell cancer within the foci of FGPs through EPS. One patient presented as metastatic GC. Progression from nondysplastic FGP to low-grade dysplasia occurred over 63 months (±46.3) with further progression to GC over 34 months (±8.5). Endoscopic risk factors for cancer were polyps >10 mm in size ( P < 0.001) and carpeting of polyps ( P < 0.001). The 5-year cumulative incidence of developing dysplasia was 35.7%. DISCUSSION: We identified that the incidence of dysplasia and GC is higher than previously reported in patients with FAP. Our study used a novel EPS technique and was able to identify GC within the foci of FGPs. Upper endoscopic guidelines should include a more rigorous sampling method for FGPs, such as EPS, to optimize early detection of dysplasia and GC.
引用
- Wang KK, Kim K, Bancila L, et al. Novel Endoscopic Polypectomy Surveillance Technique for Fundic Gland Polyps in Familial Adenomatous Polyposis Can Improve Early Detection of Dysplasia and Gastric Cancer. Am J Gastroenterol. 2022. PMID: 35584332. doi:10.14309/ajg.0000000000001833
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。